invasive breast carcinoma

Showing 26 - 50 of 70

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

HER2-Positive Breast Carcinoma, Invasive Breast Carcinoma, Metastatic Malignant Tumor in the Brain Trial in Canada, Korea,

Completed
  • HER2-Positive Breast Carcinoma
  • +4 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Birmingham, Alabama
  • +301 more
Jun 28, 2022

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial

Not yet recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +5 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Jul 14, 2022

Breast Adenocarcinoma, Invasive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United States (drug, biological, other)

Active, not recruiting
  • Breast Adenocarcinoma
  • +9 more
  • Duarte, California
  • +4 more
Jul 16, 2022

Breast Ductal Carcinoma In Situ, Invasive Breast Carcinoma Trial in Duarte (Agent Affecting Integumentary System,

Recruiting
  • Breast Ductal Carcinoma In Situ
  • Invasive Breast Carcinoma
  • Agent Affecting Integumentary System
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Jun 30, 2022

Breast Carcinoma, Invasive Breast Carcinoma Trial in Houston (procedure, other, drug)

Active, not recruiting
  • Breast Carcinoma
  • Invasive Breast Carcinoma
  • Contrast-Enhanced Mammography
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 29, 2022

Invasive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in United States

Recruiting
  • Invasive Breast Carcinoma
  • +8 more
  • Hypofractionated Radiation Therapy
  • +4 more
  • Gilbert, Arizona
  • +8 more
Jun 23, 2022

Invasive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in Detroit (Laboratory Biomarker

Active, not recruiting
  • Invasive Breast Carcinoma
  • +6 more
  • Detroit, Michigan
    Wayne State University/Karmanos Cancer Institute
Jun 17, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +12 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 16, 2022

Neoadjuvant Chemotherapy on Peripheral Blood Immune Phenotype in

Recruiting
  • Invasive Breast Carcinoma
  • Biospecimen Collection
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jun 16, 2022

Estrogen Receptor Positive, HER2/Neu Negative, Invasive Breast Carcinoma Trial in Houston (Radiation Therapy, Therapeutic

Active, not recruiting
  • Estrogen Receptor Positive
  • +3 more
  • Radiation Therapy
  • Therapeutic Conventional Surgery
  • Houston, Texas
    M D Anderson Cancer Center
Jun 14, 2022

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +21 more
  • Scottsdale, Arizona
  • +2 more
May 31, 2022

Breast Adenocarcinoma, HER2/Neu Negative, Invasive Breast Carcinoma Trial in United States (Eribulin Mesylate, Laboratory

Suspended
  • Breast Adenocarcinoma
  • +4 more
  • Eribulin Mesylate
  • +3 more
  • Scottsdale, Arizona
  • +38 more
May 25, 2022

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +22 more
  • Microbiota-based Formulation RBX7455
  • Jacksonville, Florida
    Mayo Clinic in Florida
May 12, 2022

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage II Breast Cancer AJCC v8
  • +19 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
May 11, 2022

Collecting Blood Samples From and Without Cancer to Evaluate

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +61 more
  • Questionnaire Administration
  • Biospecimen Collection
  • (no location specified)
Apr 12, 2022

Invasive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in Houston (procedure, drug,

Recruiting
  • Invasive Breast Carcinoma
  • +11 more
  • Axillary Lymph Node Dissection
  • +5 more
  • Houston, Texas
  • +1 more
Mar 10, 2022

Bilateral Breast Carcinoma, HER2/Neu Negative, Invasive Breast Carcinoma Trial in Oak Lawn, Houston (Best Practice, Ixabepilone)

Active, not recruiting
  • Bilateral Breast Carcinoma
  • +2 more
  • Oak Lawn, Illinois
  • +2 more
Mar 10, 2022

Invasive Breast Carcinoma, Triple-Negative Breast Carcinoma Trial in Houston (biological, drug, other)

Active, not recruiting
  • Invasive Breast Carcinoma
  • Triple-Negative Breast Carcinoma
  • Bevacizumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 18, 2022

Breast Cancer, Invasive Breast Carcinoma Trial in Seattle (Aerobic Exercise Intervention, Resistance Exercise Intervention,

Recruiting
  • Breast Cancer
  • Invasive Breast Carcinoma
  • Aerobic Exercise Intervention
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Feb 24, 2022

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

Active, not recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +22 more
  • Biopsy
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 25, 2022

Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8 Trial

Recruiting
  • Anatomic Stage IA Breast Cancer AJCC v8
  • +21 more
  • Trastuzumab Emtansine
  • +4 more
  • Birmingham, Alabama
  • +897 more
Feb 16, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Invasive Breast Carcinoma, Metastatic Breast Adenocarcinoma Trial in Rochester

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +4 more
  • Oncolytic Measles Virus Encoding Helicobacter pylori Neutrophil-activating Protein
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Feb 2, 2022

Benign Breast Tumor, Ductal Breast Carcinoma In Situ, Invasive Breast Carcinoma Trial in Boston, New York, Houston

Completed
  • Benign Breast Neoplasm
  • +11 more
  • Docosahexaenoic Acid
  • Placebo
  • Boston, Massachusetts
  • +3 more
Dec 3, 2021